Navigating Ipilimumab and Nivolumab Treatment for Mesothelioma: Insights from the United Kingdom
Being diagnosed with mesothelioma is tough. However, it’s vital to know about new treatments and their effects. In the United…
Navigating the Diagnosis of Mesothelioma: Insights from Expert Guidelines
Mesothelioma is a rare and hard-to-diagnose tumor. It poses challenges for patients and caregivers. However, the International Mesothelioma Interest Group…
Survival and Side Effects: Insights from RIOMeso on Mesothelioma Treatment
Mesothelioma is a hard diagnosis, especially in Australia where asbestos-related diseases are a big concern. With only a 10% survival…
Understanding Lung Cancer Care Worldwide: How Standards Impact Patients
Lung cancer affects people differently worldwide, leading to varying care practices and outcomes. To improve this, healthcare uses Clinical Quality…
Cracking the Code: SPARC, the New Mesothelioma Diagnostic Marker
Scientists from Japan have found a new mesothelioma marker called SPARC that could help doctors diagnose this rare cancer. This…
Battling Mesothelioma: How PICC Devices Make a Difference in Patients’ Lives
Mesothelioma, a rare and aggressive cancer, often takes a silent toll on the lives of those affected. This disease, linked…
Cracking the Code: Revolutionizing Mesothelioma Staging
A group of researchers from the International Association for the Study of Lung Cancer (IASLC) teamed up to help us…
Unveiling the Mesothelioma Risk Posed by Exposure to Asbestos
Asbestos is a toxic mineral found naturally throughout the world. Exposure to asbestos can cause people to develop mesothelioma, which…
Decoding the BAP1 Gene: How Family History Can Influence Tumor Risks
A group of doctors and scientists from Europe and the UK got together to create guidelines to help people with…
Breaking Down the Costs: Immunotherapy as Mesothelioma Treatment
It is not a secret that cancer treatments can be expensive. Researchers from Switzerland looked at whether immunotherapy is worth…